Page last updated: 2024-08-21
erythromycin stearate and Lung Diseases, Obstructive
erythromycin stearate has been researched along with Lung Diseases, Obstructive in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Felice-Johnson, J; Hardigan, K; Higbee, MD; Stults, BM | 1 |
Other Studies
1 other study(ies) available for erythromycin stearate and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Effect of erythromycin stearate on serum theophylline concentration in patients with chronic obstructive lung disease.
Topics: Administration, Oral; Aged; Erythromycin; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Prospective Studies; Theophylline; Time Factors | 1983 |